COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,537 Articles (22,881 medRxiv, 8,656 bioRxiv)

Most recent first Previous |  Page 748: Articles 7471-7480  | Next

Inactivated SARS-CoV-2 Reprograms the Tumor Immune Microenvironment and Improves Murine Cancer Outcomes
Giurini, E. F., Williams, M., Morin, A., Zloza, A., Gupta, K. H.
10.1101/2022.06.30.498305 — Posted: 2022-06-30
Influenza and pneumococcal vaccination and the risk of COVID-19: A systematic review and meta-analysis
Kapoula, G. V., Vennou, K. E., Bagos, P. G.
10.1101/2022.06.30.22277089 — Posted: 2022-06-30
The Citation of Retracted COVID-19 Papers is Common and Rarely Critical
Meyerowitz-Katz, G., Sekhar, P., Besancon, L., Turner, T., McDonald, S.
10.1101/2022.06.30.22277084 — Posted: 2022-06-30
Chronic fatigue, depression and anxiety symptoms in Long COVID are strongly predicted by neuroimmune and neuro-oxidative pathways which are caused by the inflammation during acute infection.
Al-Hakeim, H. K., Al-Rubaye, H. T., Almulla, A. F., Al-Hadrawi, D. S., Maes, M. F.
10.1101/2022.06.29.22277056 — Posted: 2022-06-30
RT-LAMP-CRISPR-Cas13a technology as a promising diagnostic tool for the SARS-CoV-2 virus
Ortiz-Cartagena, C., Fernandez Garcia, L., Blasco, L., Pacios, O., Bleriot, I., Lopez Diaz, M., Canton, R., Tomas, M.
10.1101/2022.06.29.22277060 — Posted: 2022-06-30
Severity of Omicron (B.1.1.529) and Delta (B.1.1.617.2) SARS-CoV-2 infection among hospitalised adults: a prospective cohort study
Hyams, C., Challen, R., Nguyen, J., Begier, E., Southern, J., King, J., Morley, A., Kinney, J., Clout, M., Oliver, J., Ellsbury, G., Maskell, N., Jodar, L., Gessner, B., McLaughlin, J., Danon, L., Finn, A.
10.1101/2022.06.29.22277044 — Posted: 2022-06-30
Inhibitory effects of GT0918 on acute lung injury and the molecular mechanisms of anti-inflammatory response
Hou, X., Yan, H., Wang, A., Liu, C., Zhou, Q., Ma, L., Chen, J., Ren, Z., Tong, Y.
10.1101/2022.06.29.498191 — Posted: 2022-06-30
Vitamin D and the ability to produce 1,25(OH)2D are critical for protection from viral infection of the lungs.
Arora, J., Patel, D. R., Nicol, M. J., Field, C. J., Restori, K. H., Wang, J., Froelich, N. E., Katkere, B., Terwilliger, J. A., Weaver, V., Luley, E., Kelly, K., Kirimanjeswara, G. S., Sutton, T. C., Cantorna, M. T.-A.
10.1101/2022.06.29.498158 — Posted: 2022-06-30
Limitations of models for guiding policy in the COVID-19 pandemic
McKeigue, P. M., Wood, S. N.
10.1101/2022.06.30.22277091 — Posted: 2022-06-30
CASP4/11 contributes to pulmonary inflammation and disease exacerbation in COVID-19
Rodrigues, T., Caetano, C., de Sa, K., Almeida, L., Becerra, A., Goncalves, A., Lopes, L., Oliveira, S., Mascarenhas, D., Batah, S., Silva, B., Gomes, G., Castro, R., Martins, R., Avila, J., Frantz, F., Cunha, T., Arruda, E., Cunha, F., Nakaya, H., Cunha, L., Fabro, A., Louzada-Junior, P., Oliveira, R., Zamboni, D. S.
10.1101/2022.06.29.22277067 — Posted: 2022-06-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).